Is Tegoprazan-Based Triple Therapy Effective in Regions with High Rates of Clarithromycin Resistance?
Gut Liver
.
2023 Sep 15;17(5):668-669.
doi: 10.5009/gnl230338.
Author
Hyun Ho Choi
1
Affiliation
1
Department of Internal Medicine, Uijeongbu St. Mary's Hospital, College of Medicine, The Catholic University of Korea, Seoul, Korea.
PMID:
37712188
PMCID:
PMC10502489
DOI:
10.5009/gnl230338
No abstract available
Publication types
Editorial
Comment
MeSH terms
Clarithromycin* / therapeutic use
Drug Resistance
Humans
Substances
Clarithromycin
tegoprazan